Privi Speciality Chemicals Past Earnings Performance
Past criteria checks 4/6
Privi Speciality Chemicals's earnings have been declining at an average annual rate of -25.8%, while the Chemicals industry saw earnings growing at 16.6% annually. Revenues have been growing at an average rate of 2.5% per year. Privi Speciality Chemicals's return on equity is 10.1%, and it has net margins of 5.4%.
Key information
-25.8%
Earnings growth rate
-26.0%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | 2.5% |
| Return on equity | 10.1% |
| Net Margin | 5.4% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Privi Speciality Chemicals makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 17,522 | 949 | 727 | 0 |
| 31 Dec 23 | 16,666 | 502 | 749 | 0 |
| 30 Sep 23 | 16,826 | 271 | 741 | 0 |
| 30 Jun 23 | 16,277 | 45 | 765 | 0 |
| 31 Mar 23 | 16,078 | 222 | 797 | 0 |
| 31 Dec 22 | 15,860 | 658 | 800 | 0 |
| 30 Sep 22 | 15,607 | 851 | 805 | 0 |
| 30 Jun 22 | 14,602 | 905 | 787 | 0 |
| 31 Mar 22 | 14,037 | 974 | 767 | 0 |
| 31 Dec 21 | 13,800 | 1,273 | 733 | 0 |
| 30 Sep 21 | 13,125 | 1,212 | 705 | 0 |
| 30 Jun 21 | 13,196 | 1,249 | 717 | 0 |
| 31 Mar 21 | 12,766 | 1,169 | 700 | 0 |
| 31 Dec 20 | 15,391 | 1,224 | 874 | 0 |
| 30 Sep 20 | 15,218 | 1,350 | 867 | 0 |
| 30 Jun 20 | 15,027 | 1,607 | 821 | 0 |
| 31 Mar 20 | 13,241 | 1,460 | 652 | 0 |
| 31 Dec 19 | 16,737 | 1,819 | 824 | 0 |
| 30 Sep 19 | 16,618 | 2,135 | 802 | 0 |
| 30 Jun 19 | 15,543 | 1,655 | 758 | 0 |
| 31 Mar 19 | 13,410 | 942 | 717 | 0 |
| 31 Dec 18 | 12,149 | 682 | 657 | 0 |
| 30 Sep 18 | 11,089 | 86 | 636 | 0 |
| 30 Jun 18 | 10,493 | 103 | 608 | 0 |
| 31 Mar 18 | 10,243 | 534 | 579 | 0 |
| 31 Dec 17 | 9,328 | 293 | 616 | 0 |
| 30 Sep 17 | 8,319 | 262 | 579 | 0 |
| 30 Jun 17 | 7,659 | 257 | 515 | 0 |
| 31 Mar 17 | 5,973 | 271 | 359 | 0 |
| 31 Dec 16 | 1,727 | 128 | 99 | 0 |
| 30 Sep 16 | 1,686 | 138 | 93 | 0 |
| 30 Jun 16 | 1,590 | 141 | 83 | 0 |
| 31 Mar 16 | 1,517 | 106 | 78 | 0 |
| 31 Dec 15 | 1,468 | 86 | 131 | 0 |
| 30 Sep 15 | 1,452 | 79 | 128 | 0 |
| 30 Jun 15 | 1,458 | 91 | 126 | 0 |
| 31 Mar 15 | 1,506 | 137 | 75 | 0 |
| 31 Dec 14 | 1,583 | 171 | 122 | 0 |
| 30 Sep 14 | 1,605 | 196 | 117 | 0 |
| 30 Jun 14 | 1,639 | 211 | 114 | 0 |
| 31 Mar 14 | 1,518 | 187 | 110 | 0 |
| 31 Dec 13 | 1,366 | 134 | 78 | 0 |
| 30 Sep 13 | 1,251 | 106 | 76 | 0 |
| 30 Jun 13 | 1,196 | 82 | 71 | 0 |
Quality Earnings: 530117 has high quality earnings.
Growing Profit Margin: 530117's current net profit margins (5.4%) are higher than last year (1.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 530117's earnings have declined by 25.8% per year over the past 5 years.
Accelerating Growth: 530117's earnings growth over the past year (327.2%) exceeds its 5-year average (-25.8% per year).
Earnings vs Industry: 530117 earnings growth over the past year (327.2%) exceeded the Chemicals industry -2.7%.
Return on Equity
High ROE: 530117's Return on Equity (10.1%) is considered low.